
The US funding would have gone towards supporting programmes for HIV/Aids treatment and prevention, tuberculosis and malaria Zimbabwe has rejected a US health deal that would have provided $367m (£272m) in funding over five years because of Washington's demand for sensitive data. The decision has come to light after a government memo from December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "lopsided".
Main Idea: Zimbabwe has rejected a large US health funding deal because it said the US wanted sensitive biological and health data without fair sharing of future benefits.
Key Points:
US taxpayers may see less clear value from health aid if Zimbabwe and other countries reject deals, while patients could face setbacks if programs lose funding.
The dispute could push US health agreements to use stricter data safeguards, which may better protect patients and consumers.
Rate how each entity in this article affected the American people.
Central country rejecting the US health funding deal and defending its position over data-sharing concerns.
Named US president whose aid cuts and policy shift are major context for the deal.
Named Zimbabwean president who reportedly viewed the deal as lopsided and whose position is central.
Zimbabwe government spokesperson who explains the government’s objections and response.
Named US ambassador quoted on winding down health assistance; important supporting official.
Central aid body referenced as the mechanism for past and current US health funding.
International body referenced in the government’s explanation of how the US approach is affecting global health structures.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentNamed professional body commenting on the deal and urging continued negotiations.
Kenyan court action is cited as relevant precedent in the article’s comparison.
Mentioned as a comparison point after a similar funding agreement was suspended there.